期刊文献+

SS-PEI/核酸纳米复合物的构建分析 被引量:2

Preparation and analysise of SS-PEI/nucleic acid complexes
原文传递
导出
摘要 目的:构建一种可生物降解的基因载体,并观察其体外转染DNA/siRNA的效率和细胞毒性。方法:采用低分子质量PEI与3,3′-二硫代二丙酸在催化剂作用下合成可降解的PEI衍生物SS-PEI,用红外波谱仪和核磁波谱仪分析其化学结构;动态光散射分析动态光散射(dynamic light scattering,DLS)SS-PEI/DNA和SS-PEI/siRNA的粒径;采用流式细胞技术(FCM)和荧光激活细胞分类术(FACS)分别分析SS-PEI对GFP-DNA和FAM-dsRNA的转染率;通过GFP表达水平分析SS-PEI对GFP质粒和GFP-siRNA的转染效率;采用考马斯蓝法分析SS-PEI/DNA和SS-PEI/siRNA的细胞毒性。结果:红外波谱和核磁波谱与SS-PEI理论波谱一致;DLS结果显示,SS-PEI/DNA复合物粒径为95~175nm,SS-PEI/siRNA平均粒径约200nm。FCM结果显示,SS-PEI对DNA的最大转染率为(25.2±2.3)%,稍低于HWPEI组的(33.8±3.1)%;SS-PEI/GFP-DNA转染后GFP的表达水平与HWPEI转染组接近〔(150±7)FI(A.U.)/mg蛋白vs(168±18)FI(A.U.)/mg蛋白〕,差异无统计学意义,t=1.62,P=0.18;细胞毒性分析显示,SS-PEI/DNA组细胞活力(89±5.2)%,显著高于HWPEI/DNA组的(70±4.9)%,差异有统计学意义,t=4.61,P=0.001。FACS结果显示,SS-PEI对FAM-dsRNA的转染率为(86.5±2.5)%;SS-PEI转染GFP-siRNA,靶基因GFP被显著敲除,相对表达水平为(42±3.5)FI(A.U.)/mg蛋白,与对照组的(79±10.8)FI(A.U.)/mg蛋白相比差异有统计学意义,t=5.64,P=0.004。结论:SS-PEI的合成可明显提高装载核酸的效率,具有低毒和高效等特点。 OBJECTIVE:To synthesize a bioreducible gene vector SS-PEI and to analyze its cytotoxicity and capacity of binding DNA and siRNA.METHODS:SS-PEI was synthesized by chemical coupling of the 3′-dithiobispropanoic acid with the low molecular weight PEI(800Da)via an EDC/NHS activation reaction.The 1HNMR spectra and Fourier transform infrared(FTIR)spectra of the SS-PEI polymer were detected,respctrively.The size of SS-PEI/DNA and SS-PEI/siRNA were measured by bynamic light scattering(DLS).The transfection rates of SS-PEI of transfecting DNA and siRNA were tested by flow chtometry(FCM)and fluorescence-activated cell sorting(FACS),respectively.Expression level of GFP protein was measured to evaluate the transfection capacity of SS-PEI mediating DNA and siRNA delivery.The cytotoxicity of SS-PEI was determined using coomassie blue staining.RESULTS:1H NMR and FTIR spectra of the polymer were in full accordance with the expected structure.The sizes of SS-PEI/DNA were in the range from 95to 175nm and the average diameter of SS-PEI/siRNA was 200nm.FCM indicated that the highest transfection rate of SS-PEI/DNA was(25.2±2.3)% which was slightly lower than that of the HWPEI/DNA(33.8±3.1)%.The expression level of GFP protein in the group SS-PEI/GFP-DNA was similar to that of the group HWPEI/GFP-DNA[(150±7)FI(A.U.)/mg protein vs(168±18)FI(A.U.)/mg protein;t=1.62,P=0.18].However,the cell viability of the group SS-PEI/DNA was significantly higher than that of the group HWPEI/DNA[(89±5.2)%vs(70±4.9)%,t=4.61,P=0.001].FACS indicated that transfection rate of SS-PEI/siRNA was(86.5±2.5)%,and the expression level of GFP protein after transfecting SS-PEI/GFP-siRNA was notably descended than that of the control group,which were(42±3.5)and(79±10.8)FI(A.U.)/mg protein,(t=5.64,P=0.004).CONCLUSION:SS-PEI can enhance the efficacy of loading DNA and siRNA and it is safe and in high performance.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2013年第19期1478-1483,共6页 Chinese Journal of Cancer Prevention and Treatment
基金 上海市第七人民医院"七院新星"基金(XX2012-028)
关键词 聚乙烯亚胺 DNA 小干扰RNA 质粒 流式细胞术 polyethylenimine DNA small interference RNA plasmid flow cytometry
  • 相关文献

参考文献2

二级参考文献27

  • 1唐致远,凌国维.纳米中药研究进展[J].中草药,2007,38(4):627-629. 被引量:8
  • 2王绍奎,张维浩,孙兰萍,孙翔宇,赵炎,左文述.乳腺癌组织中多药耐药相关蛋白的表达及其临床意义[J].中华肿瘤防治杂志,2007,14(9):692-694. 被引量:5
  • 3Tardi P G, Gallagher R C, Johnstone S, et al. Coencapsulation of irinotecan and floxuridine into low cholester-containing liposomes that coordinate drug release in vivo [J]. Biochim Biophys Acta, 2007, 1768(3): 678-687.
  • 4Cho Y W, Park S A, Han T E, el al. In vivo tumor targeting and radionuclide imaging with self assembled nanoparticles:mechanisms, key factors, and their implications[J]. Biomaterials, 2007, 28(6):1236-1247.
  • 5Noh Y W, Lim Y T, Chung B H. Noninvasive imaging of dendritic cell migration into lymph nodes using near-infrared fluorescent semiconductor nanocrystals[J]. FASEB J, 2008, 22(11):3908-3918.
  • 6Ross J S, Slodkowska E A, Symmans W F, et al. The HER-2 receptor and breast cancer: ten years of targeted anti-HER 2 therapy and personalized medicine [J]. Oncologist, 2009, 14(4) : 320-368.
  • 7Kristine M G, Karla F S, I.awrence E M, et al. Cytotoxicity and reactive oxygen species generation from aggregated carbon and carbonaceous nanoparticulatc materials [J]. Int J Nanomedicine, 2008, 3(1): 83-94.
  • 8Gradishar W J, Tjulandin S, Davidson N, et al. Phase III trial of nanoparticle albumin bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer [J]. J ClinOncol, 2005, 23(6) :7794-7803.
  • 9Sabhatini P, Aghajanian C, Dizon D, et al. Phase II study of CT 2103 in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma [J]. J Clin Oncol, 2004,22 (22): 4523 4531.
  • 10Talelli M, Rijcken C J, Lammers T, et al. Superparamagnetic i ron oxide nanoparticles encapsulated in biodegradable thermosen sitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery[J]. Langmuir, 2009,25(4) : 2960-2067.

共引文献17

同被引文献23

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部